Abstract: A paper machine for manufacturing textured soft paper comprises a press section with a press nip, through which an impermeable belt and a felt run with the fibrous web between them, a drying cylinder and a transfer roll forming a nip for transfer of the web to the drying cylinder. According to the invention the belt is a texturing belt having a back layer and a web-contacting layer having depressions with surface portions situated between them to form a relief pattern in the web upon passage through the press nip, the texturing belt running from the press to the drying cylinder in order to carry the textured web to the transfer nip. The felt runs away from the texturing belt before a water film formed in the press nip on the texturing belt breaks up. A device is provided before the transfer nip to apply adhesive on the drying cylinder.

Abstract: A paper machine for manufacturing textured soft paper comprises a press section with a press nip, through which an impermeable belt and a felt run with the fibrous web between them, a drying cylinder and a transfer roll forming a nip for transfer of the web to the drying cylinder. According to the invention the belt is a texturing belt having a back layer and a web-contacting layer having depressions with surface portions situated between them to form a relief pattern in the web upon passage through the press nip, the texturing belt running from the press to the drying cylinder in order to carry the textured web to the transfer nip. The felt runs away from the texturing belt before a water film formed in the press nip on the texturing belt breaks up. A device is provided before the transfer nip to apply adhesive on the drying cylinder.

Abstract: A medicated, lotioned tissue paper includes a substrate and a semisolid therapeutic substance carried by the substrate. In a preferred application, the therapeutic substance is a lotion for soothing irritated and sore nasal areas and for providing improved delivery of a medicinal component to a user for relief of cold and allergy symptoms. The medicinal component is evenly dispersed into the lotion or contained in microcapsules which are substantially evenly dispersed into the lotion for controlled release of the medicinal component. The medicinal component may be a medicinal scent.

Abstract: Tissue paper products comprising a two component chemical softener composition and binder materials, either permanent or temporary wet strength binders, and/or dry strength binders are disclosed. The two component chemical softening composition comprises a quaternary ammonium compound and a polysiloxane compound. Preferred quaternary ammonium compounds include dialkyl dimethyl ammonium salts such as di(hydrogenated)tallow dimethyl ammonium chloride and/or di(hydrogenated)tallow dimethyl ammonium methyl sulfate. Preferred polysiloxanes include amino-functional polydimethyl polysiloxanes wherein less than about 10 mole percent of the side chains on the polymer contain an amino-functional group.

Abstract: Tissue paper products comprising a two component chemical softener composition and binder materials, either permanent or temporary wet strength binders, and/or dry strength binders are disclosed. The two component chemical softening composition comprises an ester-functional ammonium compound and a polysiloxane compound. Preferred ester-functional ammonium compounds include diester dialkyl dimethyl ammonium salts such as diester di(touch hardened)tallow dimethyl ammonium chloride and/or di(hydrogenated)tallow dimethyl ammonium chloride. Preferred polysiloxanes include amino-functional polydimethyl polysiloxanes wherein less than about 10 mole percent of the side chains on the polymer contain an amino-functional group.

Abstract: Multi-ply facial tissue paper products comprising biodegradable chemical softener compositions and a combination of a wet strength binder, either permanent and/or temporary, and a dry strength binder is disclosed.The multi-ply facial tissue paper products contain a biodegradable chemical softening composition comprising a mixture of a biodegradable quaternary ammonium compound and a polyhydroxy compound. The multi-ply facial tissue paper products also contain an effective amount of a wet strength binder, either permanent and/or temporary, and a dry strength binder to control linting and/or to offset the loss in tensile strength, if any, resulting from the use of the biodegradable chemical softening compositions. The use of both wet strength binder, either permanent and/or temporary, and dry strength binder also improves the retention of the chemical softening composition in the sheet.

Abstract: Multi-ply facial tissue paper products comprising chemical softener compositions and a combination of a wet strength binder, permanent and/or temporary, and a dry strength binder is disclosed.The multi-ply facial tissue paper products contain a chemical softening composition comprising a mixture of a quaternary ammonium compound and a polyhydroxy compound. Preferred quaternary ammonium compounds include dialkyl dimethyl ammonium salts such as di(hydrogenated)tallow dimethyl ammonium chloride and/or di(hydrogenated)tallow dimethyl ammonium methyl sulfate. Preferred polyhydroxy compounds are selected from the group consisting of glycerol, polyglycerols having a weight average molecular weight of from about 150 to about 800, polyoxyethylene glycols and polyoxypropylene glycols having a weight average molecular weight from about 200 to 1000.